Dr. Stephanie Knatz Peck: Revolutionizing eating disorder treatment with psychedelic research

UCSD psychologist shares insights on innovative anorexia therapies in exclusive Genomic Press interview

2024-10-21

(Press-News.org) SAN DIEGO, California, 21 October 2024. In an illuminating Genomic Press Interview published today, Dr. Stephanie Knatz Peck, Associate Clinical Professor of Psychiatry at the University of California, San Diego (UCSD), unveils her groundbreaking work in eating disorder treatment and psychedelic research. The interview, featured in the journal Psychedelics, offers an intimate look at Dr. Knatz Peck's journey from personal struggle with an eating disorder to becoming a leading innovator in the field.

Dr. Knatz Peck's research uniquely bridges clinical practice with cutting-edge interventions, focusing on developing novel treatments for anorexia nervosa (AN). Her work has culminated in the development of Temperament-Based Treatment with Supports (TBT-S), a behavioral intervention that has gained international recognition.

"My hope is to support the cause to find better treatments for those suffering from treatment-resistant mental health conditions, especially eating disorders," Dr. Knatz Peck states in the interview. This mission has led her to explore the potential of psychedelic-assisted therapies, marking a significant shift in eating disorder research.

In a field-defining moment, Dr. Knatz Peck co-investigated the first clinical trial evaluating psilocybin treatment for AN. This pioneering study opens new avenues for treating a notoriously challenging condition. How might the integration of psychedelics reshape our understanding of eating disorders and their treatment?

The interview delves into Dr. Knatz Peck's unique background as a "third-culture kid," which she credits for her cognitive flexibility and openness to novel approaches. "Being extracted from this cultural framework allowed me to be consistently aware of how people and perspectives can differ throughout my life," she explains. This perspective has undoubtedly influenced her innovative approach to mental health treatment.

Dr. Knatz Peck's work extends beyond the lab, as she actively trains clinicians worldwide in TBT-S. Her collaboration with Compass Pathways in developing psychological support models for psilocybin therapy underscores the growing intersection of traditional psychotherapy and psychedelic treatments. What implications does this have for the future of mental health care, particularly for treatment-resistant conditions?

The Genomic Press Interview also offers a glimpse into Dr. Knatz Peck's personal life, revealing her passion for dance, surfing, and fashion. This holistic view of the scientist behind the research provides valuable context to her work and motivations.

As the field of psychedelic research continues to evolve, Dr. Knatz Peck's work stands out for its potential to transform the lives of those struggling with eating disorders. Her commitment to finding new models of care raises intriguing questions about the future of psychiatric treatment. How will the integration of psychedelic therapies and personalized, temperament-based approaches reshape our understanding of mental health and recovery?

Dr. Stephanie Knatz Peck’s Genomic Press interview is part of a larger series that highlights the people behind today’s most influential scientific ideas. Each interview in the series offers a blend of cutting-edge research and personal reflections, providing readers with a comprehensive view of the scientists shaping the future. By combining a focus on professional achievements with personal insights, this interview style invites a richer narrative that both engages and educates readers. This format provides an ideal starting point for profiles that delve into the scientist’s impact on the field, while also touching on broader human themes. More information on the research leaders and research rising stars featured by Genomic Press can be found in our website: https://genomicpress.com.

The full Genomic Press Interview, titled “Stephanie Knatz Peck: Novel and innovative treatment for eating disorders” is available on 21 October 2024 in Psychedelics, offering readers an in-depth look at Dr. Knatz Peck's career, her insights on the current state of eating disorder treatment, and her vision for the future of mental health care. The article is freely available online at https://pp.genomicpress.com/aop/.

About Psychedelics. Psychedelics: The Journal of Psychedelic Pharmacology (ISSN: 2997-2671) is a peer-reviewed journal published by Genomic Press, New York. Psychedelics is exclusively dedicated to the latest advancements in the realm of psychedelic substances and their potential therapeutic uses. We embrace the full spectrum of research, from fundamental investigations to cutting-edge clinical studies. Psychedelics welcomes diverse perspectives and contributions, advancing the understanding of psychedelic compounds.

END

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Male flies with shorter eyestalks make up for being less attractive by fighting more fiercely

2024-10-21

In stalk-eyed flies, longer eyestalks attract the ladies. Females prefer males with longer eyestalks, and other males are less likely to fight them for access to females. But some males have a copy of the X chromosome which always causes short eyestalks. Scientists investigating why this mutation hasn’t died out, despite sexual selection, have discovered that the flies could be compensating for their shorter eyestalks with increased aggression. “It's the first time I'm aware of that there's ...

Light-AI technology opens the door to early cancer diagnosis

2024-10-21

A research team led by Dr. Ho Sang Jung of the Advanced Bio and Healthcare Materials Research Division at the Korea Institute of Materials Science has developed an innovative sensor material that amplifies the optical signals of cancer metabolites in body fluids (saliva, mucus, urine, etc.) and analyzes them using artificial intelligence to diagnose cancer. This technology quickly and sensitively detects metabolites and changes in cancer patients' body fluids, providing a non-invasive way to diagnose cancer instead of traditional blood draws or biopsies. In collaboration with Professor Soo Woong ...

Need for Inuit-specific growth curves for accurate diagnosis and treatment

2024-10-21

Inuit children in Nunavut, Canada, are being overdiagnosed for macrocephaly and underdiagnosed for microcephaly, two neurological conditions measured by head size, because of reliance on World Health Organization (WHO) growth curves, according to new research in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.230905. “Clinicians must be able to identify children with potential medical issues appropriately, without underdiagnosis or overdiagnosis at the extremes of head circumference measurements,” writes Dr. Kristina Joyal, a pediatric neurologist, University of Manitoba and University of Saskatchewan, ...

Majority of UK public expect universities to solve climate change, poll reveals

2024-10-20

New poll shows nearly two-thirds of adults (61%) expect global research universities, such as the University of Cambridge, to come up with new innovations that will help to reduce the effects of climate change. Alternative fuels for cars and planes, improved batteries and capturing more carbon will have the greatest impact on climate change, the UK public believe. Respondents want the government to listen to universities when making climate policy, ahead of all other interest groups tested. Cambridge University is playing a leading role in ...

Black patients less likely to receive multimodal pain management options after surgery

2024-10-20

PHILADELPHIA — While recovering from major surgery, Black patients may be less likely to receive certain multimodal analgesia options and more likely to receive oral opioids than white patients, according to research being presented at the ANESTHESIOLOGY® 2024 annual meeting. Multimodal analgesia, which uses multiple types of pain medication to reduce pain, has been shown to be more effective at treating postsurgical pain than a single medication alone, particularly after complex surgeries such ...

Poor sleep quality raises the risk of delirium after surgery, study finds

2024-10-20

PHILADELPHIA — People who experience poor sleep in the month before surgery may be more likely to develop postoperative delirium, according to new research being presented at the ANESTHESIOLOGY® 2024 annual meeting. Postoperative delirium is a change in mental function that can cause confusion and occurs in up to 15% of surgical patients. In certain high-risk patients, such as those with hip fractures, the incidence can be even higher. It is a significant complication in older adults. Pain, age, stress, anxiety and insomnia are known to contribute to the risk for postoperative delirium. The researchers believe this study is the first to assess sleep quality ...

Easy-to-use tool helps screen for anxiety, depression in children having surgery

2024-10-20

PHILADELPHIA — A new, computerized, mental health assessment tool may allow doctors to quickly identify children experiencing anxiety or depression before surgery, suggests new research presented at the ANESTHESIOLOGY® 2024 annual meeting. In the small, single-center study, researchers found more than half of the children screened had anxiety before having surgery and more than one-third had depression. “The use of the KCAT® tool in pediatric patients in the preoperative setting is very feasible and the results of our pilot study show a substantial prevalence of these mental ...

Black, Asian, Hispanic trauma patients less likely to get lifesaving helicopter transport, finds first-of-its-kind study

2024-10-20

PHILADELPHIA— Severely injured Black, Asian and Hispanic children and adults are less likely than white patients to receive critical helicopter ambulance services, which can make the difference between life and death, according to a study presented at the ANESTHESIOLOGY® 2024 annual meeting. It is the first to highlight disparities in the use of helicopter ambulance transport after severe trauma. “Severely injured patients are more likely to survive if they get the right care within the ‘golden hour,’ the critical first hour after the trauma,” said Christian Mpody, M.D., Ph.D., lead author of the study and anesthesiology resident at Montefiore ...

Ibuprofen and other NSAIDs may reduce the risk of postoperative delirium

2024-10-20

PHILADELPHIA — Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, may help reduce patients’ risk of postoperative delirium, according to a study presented at the ANESTHESIOLOGY® 2024 annual meeting. “Postoperative delirium is a serious complication associated with a risk for health problems and even death after surgery,” said Steven M. Frank, M.D., co-author of the study and a professor in the Department of Anesthesiology and Critical Care Medicine at Johns Hopkins University, Baltimore. ...

Routine blood test can identify laboring women at risk for preeclampsia, prompt interventions to protect mom and baby

2024-10-19

PHILADELPHIA — A simple blood test could help doctors identify women in labor who are at risk for preeclampsia — a leading cause of maternal death — and take precautions to prevent it, according to research presented at the ANESTHESIOLOGY® 2024 annual meeting. Between 5% and 10% of pregnant women develop preeclampsia (sudden high blood pressure and protein in the urine), according to the Centers for Disease Control and Prevention (CDC). Black women are 60% more likely to develop preeclampsia than white women, ...

Dr. Stephanie Knatz Peck: Revolutionizing eating disorder treatment with psychedelic research

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: